Ananda Pharma Plc’s Post

💯

View organization page for Femtech World, graphic

19,278 followers

🍃 New research points to potential of cannabinoids in gynaecological conditions 🍃 The former British Monarch, Queen Victoria, is thought to have relied on cannabis tinctures to manage her menstrual cramps. Now, after decades of strict regulation significantly restricting research into its therapeutic properties, science may be catching up. A recent study found CBD suppositories ‘significantly reduced frequency and severity of menstrual-related symptoms’, as well as their impact on daily functioning. While researchers at the University of Edinburgh say CBD is a “promising therapeutic agent” in the treatment of endometriosis. 💬 Dr Staci Gruber, director of the Cognitive and Clinical Neuroimaging Core and Marijuana Investigations for Neuroscientific Discovery (MIND) programme and Women's Health Initiative at McLean Hospital, says: “We know that there is tremendous potential [for cannabinoids] in pain and inflammation... We should be exploring some of these compounds to try to understand how to give individuals more relief.” 💬 Melissa Sturgess, CEO of Ananda Developments Plc adds: "We are one of the first to start doing clinical trials [of CBD] in endometriosis, but there is so much evidence to suggest that CBD will be effective." Read the full story: https://lnkd.in/ePmngw5R

New research points to potential of cannabinoids in gynaecological conditions - FemTech World

New research points to potential of cannabinoids in gynaecological conditions - FemTech World

https://www.femtechworld.co.uk

To view or add a comment, sign in

Explore topics